To follow up on Marsala's post...... Vascepa marketing showing up in my wife's work email this Sunday morning .
She is a PA in dialysis !
Anyway what was interesting is that in this email blast there seemed to be an emphasis on Vascepa's positive effect on the total Lipid profile ....Not just Tg's
Amarin is casting a wide marketing net .....basically anyone in a position to write scrips for anything to do with lipid profiles will probably get this email
That is a sign of true desperation. The last marketing act you ever want to use is the dreaded "spam" unsolicited mass e-mail. Not only is it a nuisance, the sender could be fined for each violation of the SPAM-ACT.
Can't paste the design - here's the script. sends you to their website
In a clinical trial, a prescription Omega-3 lowered very high TG levels (≥500 mg/dL) in patients without increasing LDL-C
Information from Industry
Discover a new prescription Omega-3 that lowers very high triglyceride levels (≥500 mg/dL) without increasing LDL-C.
View clinical findings ›
Not sure how to do copy and paste ...will ask wife when she returns .
It's from resources@mail webmdprofessional
I guess it's what Cro and Marsala are getting .
Dsco .....it's not spam ....wife is signed up to WebMd continuing Ed and gets anything related to dialysis which includes Cardiovascular and diabetes .
More mention of reducing ApoB and benefits for diabetics etc then what I have seen in the past .
And it's not desperation ....it's aggressive marketing which is what you do whenever you are launching any new product, anywhere